9 Reasons Frozen Shoulder Is Far More Common in Perimenopause Than Doctors Acknowledge
So many women describe being handed a referral to physiotherapy without anyone once mentioning hormones — and then spending two or three years in pain wondering why their shoulder won't behave like a normal injury. The shoulder-perimenopause connection is one of those things that, once you know it, you cannot unknow it. It explains so much.
Learn more about Rose →Oestrogen Directly Regulates Collagen in Joint Capsules
The shoulder joint is encased in a fibrous capsule made largely of collagen, and oestrogen plays an active role in maintaining collagen quality, turnover, and elasticity in connective tissue throughout the body. As oestrogen declines in perimenopause, collagen production slows and existing fibres become stiffer and less pliable — creating the biological conditions in which the joint capsule can thicken and contract. This is not a coincidence of timing; it is a direct consequence of falling hormone levels on connective tissue maintenance.
The 40–60 Age Window Matches Perimenopause Almost Exactly
Adhesive capsulitis has a well-documented peak incidence between ages 40 and 60, a window that maps almost precisely onto the perimenopause and early menopause transition for most women. Women are affected at roughly twice the rate of men in this age bracket, a sex disparity that points strongly toward a hormonal driver rather than simple wear and tear. Epidemiological data consistently shows this pattern yet clinical guidance rarely frames frozen shoulder as a hormone-related condition.
Oestrogen Receptors Have Been Found in Shoulder Capsule Tissue
Research has identified oestrogen receptors (ERα and ERβ) within the fibroblasts of the glenohumeral joint capsule, confirming that shoulder tissue is genuinely responsive to circulating oestrogen levels. When oestrogen drops, these receptor sites lose their signalling input, which appears to promote the fibroblast-to-myofibroblast transformation — the cellular process that drives the pathological scarring characteristic of frozen shoulder. This is not speculative; it is a mechanistic explanation grounded in receptor biology.
Low Oestrogen Promotes a Pro-Inflammatory State in Soft Tissue
Oestrogen has well-established anti-inflammatory properties, and its decline in perimenopause shifts the body toward a low-grade, chronic inflammatory environment that affects soft tissue throughout the musculoskeletal system. In the shoulder capsule, this shift appears to accelerate the inflammatory phase of adhesive capsulitis, which then transitions into the fibrotic scarring phase more aggressively than it might in a younger, hormone-replete person. The result is a condition that often develops faster and feels more severe than the textbook description suggests.
Thyroid Dysfunction — Which Peaks in Perimenopause — Is a Known Risk Factor
Hypothyroidism is one of the most consistently identified comorbidities in frozen shoulder, and thyroid disorders become significantly more common in women during the perimenopause years, creating a compounding risk that is rarely discussed together. Thyroid hormones influence fibroblast activity and connective tissue remodelling, so when thyroid function is suboptimal alongside declining oestrogen, the shoulder capsule faces a dual hormonal challenge. Any woman in perimenopause who develops frozen shoulder without obvious cause is worth investigating for thyroid function.
Insulin Resistance — Another Perimenopause Hallmark — Triples the Risk
Type 2 diabetes and insulin resistance are among the strongest known risk factors for adhesive capsulitis, with people with diabetes developing frozen shoulder at rates two to four times higher than the general population. Insulin resistance frequently increases during perimenopause as oestrogen's protective effects on glucose metabolism are withdrawn, meaning many perimenopausal women are moving into a metabolic state that significantly raises their frozen shoulder risk even without a formal diabetes diagnosis. Elevated blood glucose promotes glycation of collagen fibres, making them rigid and prone to the kind of inflammatory changes that initiate the condition.
Sleep Deprivation From Night Sweats Impairs Tissue Repair
Connective tissue repair happens predominantly during deep sleep, when growth hormone secretion peaks and inflammatory markers drop — and perimenopause is notorious for fragmenting sleep through night sweats, anxiety, and hormonal fluctuation. A shoulder capsule already under hormonal stress has less opportunity to repair micro-damage overnight when sleep is chronically disrupted, allowing low-grade inflammation to accumulate rather than resolve. This creates a maintenance deficit in the joint that may tip vulnerable tissue toward the fibrotic cascade of frozen shoulder.
HRT Appears to Be Protective — and Possibly Therapeutic
Several observational studies have found that women using hormone replacement therapy have a lower incidence of frozen shoulder, and some clinical reports describe significant symptom improvement after HRT initiation in women who developed the condition during perimenopause. The proposed mechanism is straightforward: restoring oestrogen levels supports collagen quality, reduces capsular inflammation, and reverses the hormonal environment that allowed the condition to develop. This is not a guarantee of resolution, but it is evidence that hormonal context matters in both prevention and treatment — and it is almost never raised in standard orthopaedic consultations.
Standard Physiotherapy Protocols Were Not Designed With Perimenopausal Physiology in Mind
Most physiotherapy and corticosteroid injection protocols for frozen shoulder were developed on mixed-sex, age-varied populations without accounting for the hormonal status of the patient — meaning they may be less effective for perimenopausal women whose connective tissue is in a state of ongoing hormonal flux. Emerging evidence suggests that addressing the underlying hormonal environment alongside physical therapy produces better outcomes than physical therapy alone in this population, and that aggressive early stretching during the freezing phase can worsen inflammation in tissue already sensitised by low oestrogen. Women in perimenopause may benefit from a more graduated, lower-intensity approach to movement rehabilitation, particularly until hormonal stabilisation has been addressed.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.